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Abstract: Artificial metalloenzymes (ArMs) are hybrid cata-
lysts that offer a unique opportunity to combine the superior
performance of natural protein structures with the unnatural
reactivity of transition-metal catalytic centers. Therefore, they
provide the prospect of highly selective and active catalytic
chemical conversions for which natural enzymes are unavail-
able. Herein, we show how by rationally combining robust site-
specific phosphine bioconjugation methods and a lipid-bind-
ing protein (SCP-2L), an artificial rhodium hydroformylase
was developed that displays remarkable activities and selectiv-
ities for the biphasic production of long-chain linear aldehydes
under benign aqueous conditions. Overall, this study demon-
strates that judiciously chosen protein-binding scaffolds can be
adapted to obtain metalloenzymes that provide the reactivity of
the introduced metal center combined with specifically
intended product selectivity.
The development of substrate- and product-specific catalytic
processes that operate efficiently at mild reaction temper-
atures is a major challenge for the synthetic chemistry
community.[1] Enzymes are natureQs main catalysts and
catalyze numerous chemical transformations, typically under
benign conditions. However, many desired chemical reactions
are not performed by nature, and therefore, there are no
suitable natural enzymes. Artificial metalloenzymes (ArMs)
provide a way to bridge that gap between natural and
chemical synthesis, providing enzymes for unnatural reac-
tions.[2] Despite these successes, most ArMs do not meet the
rates and performances achieved by natural enzymes.[3] In
addition, the molecular recognition and shape selectivity of
proteins have typically not been exploited. The most success-
ful approach to create ArMs has been the use of non-covalent
anchoring strategies utilizing protein scaffolds with strong
supramolecular recognition motifs such as avidin.[4] In these
ArMs, the binding site is used to carry the active metal center
or bind metal-containing cofactors, restricting the possible
applications of the binding properties of the protein. An
alternative approach utilizes site-selective protein modifica-
tion methods[5] to incorporate transition metals into a wide
range of protein scaffolds whilst leaving the proteinQs innate
binding capabilities largely intact. Any protein scaffold can be
used, allowing the exploitation of the almost unlimited range
of highly specific substrate-binding capabilities of proteins.
Therefore, virtually any organometallic non-natural catalytic
reaction can be merged with the sophisticated biological
performance of enzymes, and this approach offers significant
opportunities for the design of ArMs aiming at high
selectivity by shape-selective product formation. Herein, we
demonstrate the potential of such ArMs through the develop-
ment of artificial rhodium enzymes derived from a protein
scaffold that was selected for its apolar substrate-binding
properties. These ArMs enable selective aldehyde formation
in the biphasic hydroformylation of long-chain linear alkenes,
a reaction for which no natural enzymes are known, and
which is challenged in current industrial applications by the
low solubility of the substrates in the aqueous phase.[6]
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We have previously reported a method that enables such
an approach for the synthesis of ArMs containing metal-
binding phosphine ligands (Scheme 1A).[5a, 7] Rhodium–phos-
phine complexes are known to be highly active and robust
hydroformylation catalysts, and thus our strategy provides the
prospect of enzymatic hydroformylation reactions. Rhodium–
protein hybrids tested to date in hydroformylation have
utilized dative protein–rhodium interactions with limited
success.[8] Although this has led to unprecedented linear
selectivities for the hydroformylation of styrene,[9] the exact
nature of the active species, and thus the origin of the
selectivity, is still unclear.[10] Rhodium-catalyzed hydroformy-
lation is used on a 800000 ton scale to produce butyraldehyde
from propene under biphasic conditions,[11] allowing for the
recovery of the expensive rhodium 3,3’,3’’-phosphanetriyl-
tris(benzenesulfonic acid) trisodium salt catalyst (Rh/
TPPTS). Long-chain aldehydes are desired by industry as
they are important precursors for the production of deter-
gents and plasticizers.[12] This process is not feasible for long-
chain alkenes (> 5 C atoms) owing to their low solubility in
water.[6]
Fatty acid transporter proteins contain apolar tunnels and
clefts to bind their hydrophobic cargo. The steroid carrier
protein type 2 like (SCP-2L) domain of the human multi-
functional enzyme 2 (MFE-2) was identified as a suitable
linear alkene binding protein scaffold as it is known to bind
a variety of linear aliphatic substrates[13] and can be obtained
in high yields.[5a] Our hypothesis was that the apolar tunnel
present in SCP-2L (Figure 1B) would be able to facilitate the
transport of alkenes to the aqueous environment and orient
the starting alkene along the tunnel towards the rhodium
center, enabling the shape-selective production of the desired
linear product (Figure 1A). To introduce the catalytic rho-
dium–phosphine complexes, two mutants containing unique
cysteines at either end of the tunnel were prepared (SCP-2L
V83C and SCP-2L A100C; Figure 1B).[5a, 14] These two
mutants, obtained in excellent yields, showed little structural
permutations and similar aliphatic substrate binding capabil-
ities as the wild-type (WT) protein (see the Supporting
Information, Table S3). Both SCP-2L mutants were success-
fully modified with aldehyde phosphines P1–P3 through
a cysteine modification strategy (Scheme 1A; for character-
ization data for SCP-2L V83C–1–(P1–P3), see Ref. [5a]; for
SCP-2L A100C–1–(P1–P3), see the Supporting Information).
The rhodium proteins (SCP-2LV83C/A100C–1–(P1–P3)–
Rh) were obtained by the addition of Rh(acac)(CO)2. Other
Rh precursors did not selectively bind to the phosphine (see
Table S4 for MS and metal loading analysis). Their catalytic
activity was investigated in the hydroformylation of 1-octene
at 35 8C and 80 bar synthesis gas (Figure 2, Scheme 1B, and
Table S5). To minimize rhodium leaching and therefore false
results from “free Rh” (leading to low selectivity (ca. 55%
linearity) and high turnover numbers (TONs> 500; Table 1,
entry 2)), a slight excess of protein (2 equiv) was used. Even
though these reactions were performed at a relatively low
temperature (typical industrial conditions are 125 8C), sig-
nificant hydroformylation activity was detected over 48 h for
several of the rhodium–phosphine ArMs (Figure 2A). Reac-
Scheme 1. A) Synthesis of the artificial metalloproteins. B) Hydrofor-
mylation of 1-octene. AA=amino acid.
Figure 1. A) The use of the apolar tunnel to introduce regioselectivity
into hydroformylation. B) The apolar tunnel in SCP-2L, showing the
position of Triton X-100 in the tunnel in the original crystal structure
(PDB No. 1IKT),[13] the tunnel dimensions, and the positions of A100
and V83.
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tions over time showed that the enzyme was active over the
whole 48 h (Table S6). Control reactions with the ArM
phosphine selenide or ArM phosphine gold complexes
showed that the rhodium was required for the hydroformy-
lation reaction to occur (Table S5).
The structure of the phosphine cofactor was found to have
a large effect on the TON, with the activity increasing by
factors of 30 and 70, respectively, as the phosphine moved
from the ortho (P1) to the meta position (P2) and from the
ortho (P1) to the para position (P3) for SCP-2L V83C. The
protein scaffold also influenced the reactivity, with a marked
improvement in turnover found when using SCP-2L A100C–
1–P3, achieving TONs of > 400, versus 75 for SCP-2LV83C–
1–P3. The selectivity of the reaction was also found to depend
on the combination of protein scaffold and phosphine
cofactor applied. It ranged from 69 to 79% for the linear
product (nonanal), matching typical selectivities for double-
phosphine-ligated rhodium-catalyzed hydroformylation.[15]
Selectivities of 80% are rarely seen with monoligated P/Rh
systems. Control reactions with P1–P3 or Rh(acac)(CO)-
(PPh3) in neat alkene showed that with monophosphines in
the organic phase of our reaction, selectivities of up to 74%
can be achieved (Tables S8 and S9). Catalyst degradation and
leaching of the phosphine and rhodium to the organic phase
were not responsible for the observed selectivities as only
minimal rhodium leaching and degradation were observed
(Table S11 and Figures S12 and S13). It should be noted that
our ArM system has a low P/Rh ratio, which, when using
a benchmark biphasic Rh/TPPTS catalytic system, only gives
activities and selectivities that correspond to rhodium leach-
ing into the organic phase (Table 1, entries 2, 4, and 5). At the
same concentration as in our ArM reactions, over 300 equiv-
alents of the TPPTS ligand are needed to prevent metal
leaching (Table 1, entries 4–6) and obtain high selectivities.
The same effect of rhodium leaching was observed when the
protein was simply mixed with Rh(acac)(CO)2 (Table 1,
entry 3). This, alongside the differences between the two
protein mutants, shows that it is the hybrid catalysts that are
responsible for the hydroformylation results. SCP-2L A100C–
1–P3 gave the best performance overall (79% nonanal,
TON= 409; Table 1, entry 1). These conversions and selec-
tivities are remarkable as a bench-
mark catalyst (Rh/TPPTS) gives
negligible conversion approaching
the detection limit (TON& 1) when
the TPPTS/Rh ratio is optimized to
give similar selectivities to the met-
alloenzyme (TPPTS/Rh= 30:1 at
ca. 10 times the Rh concentration
of the ArM reaction gives 72%
linearity; see Table S7).
Following the successful hydro-
formylation of 1-octene, these arti-
ficial metalloenzymes were tested
in the hydroformylation of 1-
decene, 1-dodecene, and 1-octade-
cene (Figure 2B).[6] When TPPTS
was used, a tenfold rate decrease
was observed on the addition of two
carbon atoms to the chain owing to the reduced water
solubility of the alkene.[6] Using the ArM, a less than fourfold
Figure 2. Activity (colored bars) and selectivity (black squares) A) of
the catalytic hydroformylation of 1-octene using different artificial
metalloenzymes (the values for P1 have been magnified) and B) for
the hydroformylation of alkenes with different chain lengths. Standard
reaction conditions: 80 bar CO/H2 (1:1), 35 8C, 625 rpm, 0.5 mL of
catalyst solution and 0.5 mL of alkene containing 9% (v/v) n-heptane
and 1% (v/v) diphenyl ether as internal standards. The Rh concen-
trations were determined by ICP-MS and used to calculate the TONs,
recorded values between 20 and 100 nmol Rh. Conversions and linear
selectivities were obtained by GC analysis with a minimum of three
runs. Error bars show the standard deviation. For further details, see
Section S4.
Table 1: Control reactions for the aqueous hydroformylation of 1-octene.
Entry Catalyst TON Linear aldehyde [%]
1 ArM: SCP-2L A100C–1–P3–Rh[a] 408.7 (57.79) 78.8 (4.86)
2 Rh(acac)(CO)2
[b] 529.7 (53.30) 55.3 (0.67)
3 protein scaffold A100C treated with Rh[c,d] 123.5 (38.19) 57.8 (0.07)
4 Rh/TPPTS (1:2)[e] 2245 (674) 58.9 (0.41)
5 Rh/TPPTS (1:20)[e] 700 (190) 56.5 (0.08)
6 Rh/TPPTS (1:300)[e] 5.4 (3.25) 65.9 (8.55)
7 Rh/TPPTS (1:300) and SCP-2L A100C[f ] 9.4 (1.01) 60.7 (1.48)
8 Rh/TPPTS (1:300) and WT SCP-2L[f ] 5.1 (2.48) 67.0 (0.64)
Standard conditions: 80 bar syngas (1:1), 35 8C, 625 rpm, 0.5 mL of catalyst solution and 0.5 mL of
1-octene containing 9% (v/v) n-heptane and 1% (v/v) diphenyl ether. The Rh concentration was
determined by ICP-MS for entry 1. Conversions and linear selectivities were obtained by GC analysis of
a minimum of three runs. Standard deviations given in parentheses. [a] P/Rh=1.5, 23 nmol Rh.
[b] 41.25 h, total volume: 0.4 mL 1-octene, no water, 150 nmol Rh. [c] Treated with Rh and washed in the
samemanner as the metalloproteins. [d] 10.0 nmol Rh. [e] 30 nmol Rh. [f ] Two equivalents of the protein
relative to Rh.
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decrease in activity was observed upon going from
1-octene to 1-decene, and an only tenfold decrease when
going to octadecene. Under selectivity-optimized conditions
(high ligand concentrations to give adequate linear selectivity
while preventing Rh leaching), Rh/TPPTS displayed no
significant activity (Figure 2A, Table 1, entry 6, and
Table S7). Control experiments using the Rh/TPPTS system
in the presence of the protein scaffold showed no significant
difference in turnover for 1-octene (Table 1, entry 6 vs. 7 and
8), providing evidence that the increase in activity for the
ArMs cannot solely be explained by the protein acting as
a phase-transfer reagent. We therefore attribute the higher-
than-expected activity to the presence of the lipid-binding
tunnel in the protein scaffold in direct proximity of the Rh
center.
Overall, the selectivities for the linear hydroformylation
products were remarkably high for monophosphine-ligated
rhodium in water, indicating that the protein scaffold counter-
balances the lack of phosphine ligands. In addition, both the
phosphine cofactor and the protein mutant affect the activity
of the reaction. To better understand the observed selectivity
of our hydroformylase, we investigated the local environment
of the Rh center in the protein scaffold. Both the X-ray
absorption near-edge structure (XANES) and extended X-
ray absorption fine structure (EXAFS) of SCP-2L A100C–1–
P3–Rh at the Rh K edge were assessed. Comparing the
XANES of SCP-2L A100C–1–P3–Rh to model Rh complexes
(Figure S10) suggested the loss of carbonyl functionalities
from the Rh(acac)(CO)2 precursor. This was further sup-
ported by the lack of CO stretches in the IR spectrum and
fitting the EXAFS data of SCP-2L A100C–1–P3–Rh
(Table S1).
The fitting model applied used characteristic scattering
paths from both acac and PPh2Ar ligands, with a derived Rh–
P coordination number of two. EXAFS is unable to distin-
guish between scattering neighbors of like atomic number,
especially where Z=: 1. The prospect of two phosphorus
atoms coordinated to the rhodium center appeared unlikely
owing to the steric congestion resulting from placing two
protein scaffolds around the metal. Thus we postulated the
possibility of one of the observed Rh–P neighbors arising
from a Rh–S interaction (Figure 3A); the protein scaffold
contains functionalized sulfur in the form of methionine, at
the N-terminus and on the flexible a-helices, and the
introduced cysteine (Figure 3B).
To probe the possibility of a nearby methionine coordi-
nating to the Rh center, the selenomethionine derivatives of
the protein scaffold were expressed and purified. Rhodium
complexation of the phosphine-modified SeMet protein with
Rh(acac)(CO)2 gave similar results as for SCP-2L A100C–1–
P3, showing the RhCO adducts in the mass spectra, and also
resulted in a small shift in the 77Se NMR spectrum upon Rh
addition (Figure S11). There was a profound change in the Rh
K edge EXAFS data of SeMet-A100C–1–P3–Rh compared
to SCP-2L A100C–1–P3–Rh (Figure 3C). The differences
observed can be rationalized by coordination to a neighbor of
higher atomic number with a larger backscattering amplitude;
between the analogous systems, Rh–S interactions have been
replaced by Rh–Se interactions. The EXAFS analysis sup-
ports our hypothesis that there is monophosphine coordina-
tion, coupled with further interaction with sulfur from
a methionine residue. Moreover, through observation of this
Rh–S/Se interaction, we have direct evidence for the coordi-
nation of the protein scaffold to the Rh center.
We were intrigued if the methionine coordination would
have an effect on the catalytic performance of the ArM, or if
the methionine would just decoordinate under the reaction
conditions to give the same active catalyst, and thus the same
catalytic results in all cases. To probe this further, four
mutants of SCP-2L A100C were prepared in which each Met
residue was replaced by alanine, and the proteins were then
modified as above. The results of the initial catalytic experi-
ments are ambiguous; the activity of SCP-2L A100CM105A–
1–P3 was on average higher than that of A100C or the other
mutants (TON= 112(: 33) and TON= 60–86 for the others,
see Table S10), which could indicate that M105 is indeed
involved in rhodium coordination. However, this can also be
due to other factors, such as structural changes or decreased
protein stability. More detailed studies are required before
Figure 3. A) Cartoon of the hypothesized metal environment. B) Model
of A100C (Swiss model) with 1–P3 docked using gold to illustrate the
reach of this added cofactor. Methionine residues within range are
highlighted in yellow. C) The k3-weighted Rh K edge EXAFS data (black
lines) and associated fit (dashed red line) for A100C–1–P3–Rh and
SeMet-A100C–1–P3–Rh.
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firm conclusions can be drawn on the role of the methionine
residues in the hydroformylation by these ArMs.
In summary, we have shown that rhodium phosphine
modified SCP-2Ls are linear-selective catalysts in the hydro-
formylation of long-chain alkenes. SCP-2L A100C–1–P3–Rh
showed a rate enhancement of at least 103 compared to the
traditional Rh/TPPTS system in the biphasic hydroformyla-
tion of 1-octene and 1-decene. This demonstrates that
a protein chosen for its specific binding properties can be
converted into an enzyme in which these properties are used
to transmit product selectivity. Combining this technology
with the recent advances in chemical biology will allow us to
rapidly engineer highly selective catalysts that operate under
benign conditions. Moving forward, we believe that this
approach has the potential to be used for a whole range of
reactions that traditionally use phosphines as ligands and to
convert these into biocatalytic processes. In the long term, as
chemogenetic optimization is used to improve activity, this
could open the door to a new era of biocatalytic chemical
production.
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